Which of the following medications could potentially cause impaired renal function: pantoprazole (Protonix), fenofibrate (Tricor), enalapril maleate (Vasotec), insulin (Lantus, NovoLOG), apixaban (Eliquis), aspirin, famotidine (Pepcid), amlodipine (Norvasc), magnesium, Vitamin D2, atorvastatin (Lipitor), and tramadol (Ultram)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications That Could Potentially Harm Kidney Function

Among the listed medications, enalapril, fenofibrate, and aspirin have the highest potential to cause impaired renal function, with enalapril posing the most significant risk in vulnerable patients. 1, 2, 3

High-Risk Medications for Kidney Function

Enalapril (ACE Inhibitor)

  • Mechanism of kidney harm: Inhibits the renin-angiotensin-aldosterone system, which can reduce renal perfusion 1
  • Risk factors for kidney injury:
    • Severe heart failure (renal function dependent on renin-angiotensin system)
    • Bilateral renal artery stenosis
    • Pre-existing renal impairment
    • Concomitant use of diuretics
    • Volume depletion/dehydration
    • Elderly patients 4, 5
  • Warning signs: Increases in blood urea nitrogen and serum creatinine (usually reversible upon discontinuation) 1

Fenofibrate

  • Mechanism of kidney harm: Can cause direct nephrotoxicity
  • Risk considerations:
    • Requires dose reduction in mild to moderate renal impairment (54 mg/day)
    • Should be avoided in severe renal impairment 2
    • Requires monitoring of renal function before and during treatment 6

Aspirin (Low Dose)

  • Mechanism of kidney harm: Reduces renal prostaglandin production, affecting renal perfusion
  • Risk considerations:
    • Even at low doses (81mg), can contribute to volume-dependent renal failure
    • Risk increases when combined with ACE inhibitors (like enalapril) and diuretics 3
    • Part of the "triple whammy" combination (ACE inhibitor/ARB + diuretic + NSAID) that significantly increases AKI risk 3

Moderate-Risk Medications

Pantoprazole and Famotidine

  • Generally considered safe for kidneys at recommended doses
  • Rare cases of acute interstitial nephritis reported with PPIs like pantoprazole, but uncommon

Amlodipine

  • Generally safe for kidney function
  • May actually have renoprotective effects in some patients 6

Low-Risk Medications

Insulin (Lantus, NovoLOG)

  • No direct nephrotoxic effects
  • Important for glycemic control which helps preserve kidney function

Apixaban

  • Lower renal clearance compared to other anticoagulants
  • Dose of 2.5mg twice daily already accounts for potential renal concerns

Atorvastatin

  • Generally safe for kidney function
  • No dose adjustment required in renal impairment

Tramadol

  • Primarily metabolized by the liver
  • Dose adjustment recommended in severe renal impairment, but not directly nephrotoxic

Vitamin D2 and Magnesium

  • Generally safe at recommended doses
  • Magnesium should be used cautiously in severe renal impairment due to risk of accumulation

Monitoring Recommendations

  1. Regular kidney function testing:

    • Baseline renal function before starting enalapril or fenofibrate
    • Follow-up testing 1-2 weeks after initiation or dose changes
    • More frequent monitoring in high-risk patients 3
  2. Warning signs of nephrotoxicity:

    • Serum creatinine increase >30%
    • eGFR decrease >25%
    • Hyperkalemia (K+ >5.5 mmol/L)
    • New onset or worsening edema
    • Unexplained fatigue or nausea 3
  3. Precautions with multiple medications:

    • Avoid the "triple whammy" combination (enalapril + diuretic + aspirin)
    • Ensure adequate hydration, especially with enalapril
    • Consider temporary holding enalapril during acute illness with dehydration 3

Key Clinical Pitfalls to Avoid

  1. Never add an NSAID (even OTC) to a patient already on enalapril without careful monitoring of renal function 4

  2. Avoid volume depletion in patients taking enalapril - this significantly increases the risk of acute kidney injury 1

  3. Monitor for hyperkalemia in patients taking enalapril, especially if they have pre-existing renal impairment 1

  4. Recognize that fenofibrate requires dose adjustment in renal impairment and should be avoided in severe renal dysfunction 2

  5. Be aware that even low-dose aspirin can contribute to renal dysfunction, particularly when combined with enalapril 3

References

Guideline

Medication-Related Kidney Function Risks

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[ACE inhibitors and the kidney].

Wiener medizinische Wochenschrift (1946), 1996

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.